An elevated expression level of ABCG2 in the cancer cells can be closely associated with the difficulty in 5‐ALA–based discrimination between cancer (MCF7, MDA‐MB‐231) and noncancer (MCF10A) cell lines in flow cytometry. Here, ABCG2 is linked to cancer.